FDA unveils landmark pathway in latest push to accelerate rare disease drug approvals

The US FDA has unveiled a significant regulatory advance with the introduction of its Rare Disease Evidence Principles, the latest example of a growing global momentum to accelerate the development and approval of therapies targeting rare diseases. …